Texas, USA-based Nanoscope Therapeutics has recently submitted a rolling biologics license application (BLA) to the Food and ...

Hungary’s largest drugmaker Gedeon Richter has announced the UK launch of Nalvee (10mg dydrogesterone), a highly bioavailable oral progestogen tablet for hormone replacement therapy (HRT).

The UK’s National Health Service (NHS) and local authorities have started the rollout of world-first gonorrhoea vaccination ...

Noom’s Microdose GLP-1Rx Program is priced at $119 to start, followed by $199 per month, which includes medication, if ...

Privately-held US clinical-stage biotech Cellergy Pharma announced the appointment Christopher Cano as chief executive (CEO).

Shares of Vertex Pharmaceuticals plunged more than 14% to $404.89 after it release disappointing top-line results from its recently completed Phase II, randomized, double-blind, placebo-controlled ...

A New York-based healthcare investment firm has announced that it has raised $1.86 billion in commitments for OrbiMed Royalty ...

Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...

The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...

Germany’s BioNTech has reported revenues for the second quarter 2025 of 260.8 million euros ($302 million), more than double ...

Biosimilars, once met with skepticism, are now an undeniable force in the global pharmaceutical market. As several ...

Philadelphia, USA-based Medicus Pharma and Boston-based biotech Helix Nanotechnologies have entered into a non-binding ...